Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −8,167−100.0% | Sold out | Holders |
| Q4 2025 | 8,167 | $713.3K | <0.1% | +8,167 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −173,134−100.0% | Sold out | Holders |
| Q2 2025 | 173,134 | $9.57M | <0.1% | −150,433−46.5% | Reduced | Holders |
| Q1 2025 | 323,567 | $15.6M | <0.1% | +102,400+46.3% | Added | Holders |
| Q4 2024 | 221,167 | $8.54M | <0.1% | +77,000+53.4% | Added | Holders |
| Q3 2024 | 144,167 | $6.49M | <0.1% | −153,300−51.5% | Reduced | Holders |
| Q2 2024 | 297,467 | $10.3M | <0.1% | +264,900+813.4% | Added | Holders |
| Q1 2024 | 32,567 | $942.0K | <0.1% | −181,400−84.8% | Reduced | Holders |
| Q4 2023 | 213,967 | $4.91M | <0.1% | −12,301−5.4% | Reduced | Holders |
| Q3 2023 | 226,268 | $3.77M | <0.1% | −163,999−42.0% | Reduced | Holders |
| Q2 2023 | 390,267 | $10.8M | <0.1% | −300,600−43.5% | Reduced | Holders |
| Q1 2023 | 690,867 | $15.9M | <0.1% | +432,000+166.9% | Added | Holders |
| Q4 2022 | 258,867 | $2.82M | <0.1% | −140,900−35.2% | Reduced | Holders |
| Q3 2022 | 399,767 | $3.37M | <0.1% | +76,900+23.8% | Added | Holders |
| Q2 2022 | 322,867 | $2.55M | <0.1% | +303,400+1,558.5% | Added | Holders |
| Q1 2022 | 19,467 | $461.0K | <0.1% | +19,467 | New | Holders |